Ardelyx (ARDX) Operating Expenses (2013 - 2026)
Ardelyx (ARDX) reported Operating Expenses of $127.3 million for Q1 2026, up 15.21% on a YoY basis from $110.5 million in Q1 2025, and down 14.47% quarter-over-quarter from $148.8 million in Q4 2025.
Ardelyx (ARDX) Operating Expenses (2013 - 2026) Analysis & Trends
Ardelyx has reported Operating Expenses for 14 years, with the latest figure at $127.3 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 15.21% year-over-year to $127.3 million; the trailing twelve-month figure through Mar 2026 stood at $477.4 million (up 16.88% YoY), and the FY2025 full-year result was $448.3 million, up 23.99% from the prior year.
- Operating Expenses for Q1 2026 stood at $127.3 million, down from $148.8 million in the prior quarter.
- The five-year high for Operating Expenses was $148.8 million in Q4 2025, with the low at $26.1 million in Q3 2022.
- Historically, Operating Expenses has averaged $73.5 million across 5 years, with a median of $75.1 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses sank 39.8% — and 2023, when it surged 159.99%.
- Ardelyx's Operating Expenses stood at $28.9 million in 2022, then surged by 159.99% to $75.1 million in 2023, then jumped by 86.89% to $140.3 million in 2024, then climbed by 6.06% to $148.8 million in 2025, then dropped by 14.47% to $127.3 million in 2026.
- The last three Operating Expenses figures came in at $127.3 million (Q1 2026), $148.8 million (Q4 2025), and $101.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 127.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 127.27 Mn |
| Dec 31, 2025 | 148.80 Mn |
| Sep 30, 2025 | 101.68 Mn |
| Jun 30, 2025 | 99.65 Mn |
| Mar 31, 2025 | 110.46 Mn |
| Dec 31, 2024 | 140.30 Mn |
| Sep 30, 2024 | 80.28 Mn |
| Jun 30, 2024 | 77.42 Mn |
| Mar 31, 2024 | 63.57 Mn |
| Dec 31, 2023 | 75.07 Mn |
| Sep 30, 2023 | 41.30 Mn |
| Jun 30, 2023 | 35.47 Mn |
| Mar 31, 2023 | 35.90 Mn |
| Dec 31, 2022 | 28.87 Mn |
| Sep 30, 2022 | 26.13 Mn |
| Jun 30, 2022 | 28.60 Mn |
| Mar 31, 2022 | 28.28 Mn |
| Dec 31, 2021 | 35.30 Mn |
| Sep 30, 2021 | 43.41 Mn |
| Jun 30, 2021 | 46.15 Mn |